Involvement of the urokinase kringle domain in lipopolysaccharide-induced acute lung injury

Journal of Immunology

Volumn 177, Issue 8, 2006, Pages 5550-5557

  Wang, Xue Qing ^a   Bdeir, Khali ^b   Yarovoi, Sergei ^b   Cines, Douglas B ^b   Fang, Wenfeng ^a,d   Abraham, Edward ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c University of Alabama at Birmingham   (United States)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MYELOPEROXIDASE; PROTEIN KINASE B; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UROKINASE;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOLYSIS; GEL MOBILITY SHIFT ASSAY; GRAM NEGATIVE INFECTION; HISTOPATHOLOGY; INFLAMMATION; KRINGLE DOMAIN; LEUKOCYTE ACTIVATION; LUNG EDEMA; LUNG HOMOGENATE; LUNG LAVAGE; LUNG WEIGHT; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 33749535411     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.8.5550     Document Type: Article

References (45)

1. Rijneveld, A. W., M. Levi, S. Florquin, P. Speelman, P. Carmeliet, and T. van Der Poll. 2002. Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia. J. Immunol. 168: 3507-3511.
2. 2 integrins in vivo. J. Exp. Med. 188: 1029-1037.
3. Hansen, A. P., A. M. Petros, R. P. Meadows, D. G. Nettesheim, A. P. Mazar, E. T. Olejniczak, R. X. Xu, T. M. Pederson, J. Henkin, and S. W. Fesik. 1994. Solution structure of the amino-terminal fragment of urokinase-type plasminogen activator. Biochemistry 33: 4847-4864.
4. Abraham, E., M. R. Gyetko, K. Kuhn, J. Arcaroli, D. Strassheim, J. S. Park, S. Shelly, and S. Idell. 2003. Urokinase-type plasminogen activator potentiates lipopolysaccharide-induced neutrophil activation. J. Immunol. 170: 5644-5651.
5. Choi, G., M. J. Schultz, J. W. van Till, P. Bresser, J. S. van der Zee, M. A. Boermeesler, M. Levi, and T. van der Poll. 2004. Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection. Eur. Respir. J. 24: 786-789.
6. Levi, M., M. J. Schultz, A. W. Rijneveld, and T. van der Poll. 2003. Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia. Crit. Care Med. 31: S238-242.
7. Blasi, F. 1997. uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways? Immunol. Today 18: 415-417.
8. Chavakis, T., S. M. Kanse, A. E. May, and K. T. Preissner. 2002. Haemostatic factors occupy new territory: the role of the urokinase receptor system and kininogen in inflammation. Biochem. Soc. Trans. 30: 168-173.
9. Quax, P. H. A., J. M. Grimbergen, M. Lansink, A. H. F. Bakker, M.-C. Blatter, D. Belin, V. W. M. van Hinsbergh, and J. H. Verheijen. 1998. Binding of human urokinase-type plasminogen activator to its receptor: residues involved in species specificity and binding. Arterioscler. Thromb. Vasc. Biol. 18: 693-701.
10. Blasi, F., and P. Carmeliet. 2002. uPAR: a versatile signalling orchestrator. Nat. Rev. Mol. Cell Biol. 3: 932-943.
11. 3 integrins. J. Leukocyte Biol. 78: 937-945.
12. Rubenfeld, G. D., E. Caldwell, E. Peabody, J. Weaver, D. P. Martin, M. Neff, E. J. Stern, and L. D. Hudson. 2005. Incidence and outcomes of acute lung injury. N. Engl. J. Med. 353: 1685-1693.
13. Ware, L. B., and M. A. Matthay. 2000. The acute respiratory distress syndrome. N. Engl. J. Med. 342: 1334-1349.
14. Bdeir, K., A. Kuo, B. S. Sachais, A. H. Rux, Y. Bdeir, A. Mazar, A. A. Higazi, and D. B. Ones. 2003. The kringle stabilizes urokinase binding to the urokinase receptor. Blood 102: 3600-3608.
15. Haj-Yehia, A., T. Nassar, B. S. Sachais, A. Kuo, K. Bdeir, A. B. Al-Mehdi, A. Mazar, D. B. Cines, and A. A. Higazi. 2000. Urokinase-derived peptides regulate vascular smooth muscle contraction in vitro and in vivo. FASEB J. 14: 1411-1422.
16. Nassar, T., A. Haj-Yehia, S. Akkawi, A. Kuo, K. Bdeir, A. Mazar, D. B. Cines, and A. A. Higazi. 2002. Binding of urokinase to low density lipoprotein-related receptor (LRP) regulates vascular smooth muscle cell contraction. J. Biol. Chem. 277: 40499-40504.
17. Asehnoune, K., D. Strassheim, S. Mitra, J. Y. Kim, and E. Abraham. 2004. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-κB. J. Immunol. 172: 2522-2529.
18. 2: disparate effects on kinases, NF-κB, and cytokine expression. Am. J. Physiol. 286: C683-C692.
19. Abraham, E., J. Arcaroli, A. Carmody, H. Wang, and K. J. Tracey. 2000. HMG-1 as a mediator of acute lung inflammation. J. Immunol. 165: 2950-2954.
20. Rowe, S. J., L. Allen, V. C. Ridger, P. G. Hellewell, and M. K. B. Whyte. 2002. Caspase-1-deficient mice have delayed neutrophil apoptosis and a prolonged inflammatory response to lipopolysaccharide-induced acute lung injury. J. Immunol. 169: 6401-6407.
21. Asti, C., V. Ruggieri, S. Porzio, R. Chiusaroli, G. Melillo, and G. F. Caselli. 2000. Lipopolysaccharide-induced lung injury in mice. I. Concomitant evaluation of inflammatory cells and haemorrhagic lung damage. Pulm. Pharmacol. Ther. 13: 61-69.
22. Abraham, E., S. Bursten, R. Shenkar, J. Allbee, R. Tuder, P. Woodson, D. M. Guidot, G. Rice, J. W. Singer, and J. E. Repine. 1995. Phosphatidic acid signaling mediates lung cytokine expression and lung inflammatory injury after hemorrhage in mice. J. Exp. Med. 181: 569-575.
23. Parsey, M. V., D. Kaneko, R. Shenkai, and E. Abraham. 1999. Neutrophil apoptosis in the lung after hemorrhage or endotoxemia: apoptosis and migration are independent of interleukin-1β. Chest 116: 67S-68S.
24. Parsey, M. V., R. M. Tuder, and E. Abraham. 1998. Neutrophils are major contributors to intraparenchymal lung IL-1β expression after hemorrhage and endotoxemia. J. Immunol. 160: 1007-1013.
25. Abraham, E., W. F. Coulson, M. D. Schwartz, and I. Allbee. 1994. Effects of therapy with soluble tumour necrosis factor receptor fusion protein on pulmonary cytokine expression and lung injury following haemorrhage and resuscitation. Clin. Exp. Immunol. 98: 29-34.
26. Abraham, E., A. Carmody, R. Shenkar, and J. Arcaroli. 2000. Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. Am. J. Physiol. 279: L1137-L1145.
27. Yum, H. K., J. Arcaroli, J. Kupfner, R. Shenkar, J. M. Penninger, T. Sasaki, K. Y. Yang, J. S. Park, and E. Abraham. 2001. Involvement of phosphoinositide 3-kinases in neutrophil activation and the development of acute lung injury. J. Immunol. 167: 6601-6608.
28. Arcaroli, J., K. Y. Yang, H. K. Yum, J. Kupfner, T. M. Pitts, J. S. Park, D. Strassheim, and E. Abraham. 2002. Effects of catecholamines on kinase activation in lung neutrophils after hemorrhage or endotoxemia. J. Leukocyte Biol. 72: 571-579.
29. Nick, J. A., S. K. Young, P. G. Arndt, J. G. Lieber, B. T. Suratt, K. R. Poch, N. J. Avdi, K. C. Malcolm, C. Taube, P. M. Henson, and G. S. Worthen. 2002. Selective suppression of neutrophil accumulation in ongoing pulmonary inflammation by systemic inhibition of p38 mitogen-activated protein kinase. J. Immunol. 169: 5260-5269.
30. Arcaroli, J., H. K. Yum, J. Kupfner, J. S. Park, K. Y. Yang, and E. Abraham. 2001. Role of p38 MAP kinase in the development of acute lung injury. Clin, Immunol. 101: 211-219.
31. van der Poll, T., M. Levi, J. A. Nick, and E. Abraham. 2005. Activated protein C inhibits local coagulation after intrapulmonary delivery of endotoxin in humans. Am. J. Respir. Crit. Care Med. 171: 1125-1128.
32. Rijneveld, A. W., S. Florquin, P. Bresser, M. Levi, V. De Waard, R. Lijnen, J. S. Van Der Zee, P. Speelman, P. Carmeliet, and T. Van Der Poll. 2003. Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumonia. Blood 102: 934-939.
33. Maris, N. A., A. F. de Vos, P. Bresser, J. S. van der Zee, J. C. Meijers, H. R. Lijnen, M. Levi, H. M. Jansen, and T. van der Poll. 2005. Activation of coagulation and inhibition of fibrinolysis in the lung after inhalation of lipopolysaccharide by healthy volunteers. Thromb. Haemost. 93: 1036-1040.
34. Schultz, M. J., J. Millo, M. Levi, C. E. Hack, G. J. Weverling, C. S. Garrard, and T. van der Poll. 2004. Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Thorax 59: 130-135.
35. Czekay, R. P., K. Aertgeerts, S. A. Curriden, and D. J. Loskutoff. 2003. Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins. J. Cell Biol. 160: 781-791.
36. 3 induces signal transduction and enhances plasminogen activation. Thromb. Haemost. 95: 524-534.
37. Mimuro, J., M. Kaneko, T. Murakami, M. Matsuda, and Y. Sakata. 1992. Reversible interactions between plasminogen activators and plasminogen activator inhibitor-1. Biochim. Biophys. Acta 1160: 325-334.
38. Mukhina, S., V. Stepanova, D. Traktouev, A. Poliakov, R. Beabealashvilly, Y. Gursky, M. Minashkin, A. Shevelev, and V. Tkachuk. 2000. The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain: characterization of interactions and contribution to chemotaxis. J. Biol. Chem. 275: 16450-16458.
39. Schultz, M. J., J. J. Haitsma, H. Zhang, and A. S. Slutsky. 2006. Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia-a review. Crit. Care Med. 34: 871-877.
40. Ware, L. B., J. A. Bastarache, and L. Wang. 2005. Coagulation and fibrinolysis in human acute lung injury-new therapeutic targets? Keio J. Med. 54: 142-149.
41. Strassheim, D., K. Asehnoune, J. S. Park, J. Y. Kim, Q. He, D. Richter, K. Kuhn, S. Mitra, and E. Abraham. 2004. Phosphoinositide 3-kinase and Akt occupy central roles in inflammatory responses of Toll-like receptor 2-stimulated neutrophils. J. Immunol. 172: 5727-5733.
42. Akashi, S., H. Ogata, F. Kirikae, T. Kirikae, K. Kawasaki, M. Nishijima, R. Shimazu, Y. Nagai, K. Fukudome, M. Kimoto, and K. Miyake. 2000. Regulatory roles for CD14 and phosphatidylinositol in the signaling via Toll-like receptor 4-MD-2. Biochem. Biophys. Res. Commun. 268: 172-177.
43. Francois, S., J. El Benna, P. M. Dang, E. Pedruzzi, M. A. Gougerot-Pocidalo, and C. Elbim. 2005. Inhibition of neutrophil apoptosis by TLR agonists in whole blood: involvement of the phosphoinositide 3-kinase/Akt and NF-κB signaling pathways, leading to increased levels of Mcl-1, A1, and phosphorylated Bad. J. Immunol. 174: 3633-3642.
44. Tracey, K. J., and E. Abraham. 1999. From mouse to man: or what have we learned about cytokine-based anti-inflammatory therapies? Shock 11: 224-225.
45. Dinarello, C. A., and E. Abraham. 2002. Does blocking cytokines in sepsis work? Am. J. Respir. Crit. Care Med. 166: 1156-1157.